IBYME 02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
FXYD5/Dysadherin Is A New Marker Of Prostate Cancer Progression And Aggressiveness Associated To Epithelial-To-Mesenchymal Transition.
Autor/es:
ROSSO, M; VAZQUEZ, M.H.; MENCUCCI MV; MOIOLA C; BELLO, R.; BESSO MJ
Lugar:
Munster
Reunión:
Congreso; 12th International, 11th European, 32nd German Congress of Andrology.; 2020
Institución organizadora:
International Society of Andrology
Resumen:
MENCUCCI, MV, BELLO, R, ROSSO M, MOIOLA C, BESSO MJ, VAZQUEZ-LEVIN MH (presentado por MVL). FXYD5/Dysadherin Is A New Marker Of Prostate Cancer Progression And Aggressiveness Associated To Epithelial-To-Mesenchymal Transition. 12th International, 11th European, 32nd German Congress of Andrology. Germany (Virtual) Nov 2020. Journal of Reproductive Medicine and Endocrinology (Krause & Pachernegg GmbH)
